Skip to content
PharmaInsight

Co-beneldopa (Benserazide/levodopa)

National NHS prescribing (Prescription Cost Analysis) · Drugs used in parkinsonism and related disorders
Data updated March 2026

Co-beneldopa (Benserazide/levodopa) was ranked 205th of 1,794 medicines by items in March 2026, with 79,414 items, up 3.1% on a year earlier.

79,414items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£886,111

Net ingredient cost · March 2026

NHSBSA PCA

949,699items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Co-beneldopa (Benserazide/levodopa): national items dispensed by month

79,414

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

Top presentations, March 2026

The individual products dispensed under Co-beneldopa (Benserazide/levodopa), by items this month.

Presentations of Co-beneldopa (Benserazide/levodopa), March 2026
Presentation Items Net ingredient cost
Co-beneldopa 12.5mg/50mg capsules 16,934 £253,535
Co-beneldopa 25mg/100mg capsules 15,267 £142,021
Madopar CR capsules 11,887 £156,509
Madopar 50mg/12.5mg dispersible tablets 10,327 £73,396
Madopar 100mg/25mg capsules 10,107 £100,727
Madopar 50mg/12.5mg capsules 9,266 £78,730
Madopar 100mg/25mg dispersible tablets 3,513 £49,481
Co-beneldopa 50mg/200mg capsules 1,209 £17,705
Madopar 200mg/50mg capsules 904 £14,006

Compare Co-beneldopa (Benserazide/levodopa) with

Other medicines in the same BNF section, by prescribing volume.